TherapeuticsMD, Inc. — Director's Dealing 2013

Aug 28, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2013-08-26

Reporting Person: SEGAL NICHOLAS (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-08-26	Common Stock	P	74128	$1.55	Acquired	730723	Indirect

Footnotes

F1: Seavest Capital Ventures, LLC acquired 1,600,000 shares of TXMD's Common Stock. Mr. Segal owns 4.633% of Seavest Capital Ventures, LLC. Mr. Segal disclaims benefical ownership of these securities except to the extent of his pecuniary interest therein.

F2: Fourth Generation Private Equity owns 3,549,805 shares of TXMD's Common Stock. Mr. Segal owns 11.58% of Fourth Generation Private Equity. Mr. Segal disclaims benefical ownership of these securities except to the extent of his pecuniary interest therein.